• LAST PRICE
    0.4300
  • TODAY'S CHANGE (%)
    Trending Up0.0070 (1.6548%)
  • Bid / Lots
    0.4224/ 4
  • Ask / Lots
    0.4300/ 50
  • Open / Previous Close
    0.4226 / 0.4230
  • Day Range
    Low 0.4100
    High 0.4398
  • 52 Week Range
    Low 0.2300
    High 3.1000
  • Volume
    59,674
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.423
TimeVolumeONCR
09:32 ET2000.4226
09:33 ET1000.4398
09:35 ET1110.439699
09:48 ET29670.4223
09:50 ET31000.4299
09:51 ET30000.429899
09:53 ET20000.4225
10:04 ET2000.4299
10:06 ET4000.4262
10:08 ET6000.4236
10:09 ET73920.4222
10:11 ET3130.4222
10:18 ET1000.4222
10:20 ET1000.4222
10:24 ET13010.4223
10:26 ET36730.4222
10:27 ET2000.4222
10:29 ET1000.4223
10:38 ET20000.4223
10:49 ET1000.4223
10:56 ET2010.4222
11:00 ET1000.4223
11:02 ET3000.4222
11:03 ET4910.4222
11:05 ET14470.42
11:07 ET2000.4101
11:14 ET63000.4166
11:18 ET5000.41
11:20 ET2000.423
11:25 ET41000.423
11:32 ET1000.423
11:38 ET2120.423
11:48 ET6000.423
11:57 ET1000.423
12:01 ET1000.423
12:03 ET5880.423
12:08 ET4000.423
12:14 ET2000.423
12:17 ET1000.423
12:21 ET6000.423
12:32 ET1000.423
12:37 ET7000.423
12:48 ET2000.4165
12:55 ET6000.423
01:02 ET1000.4165
01:08 ET2000.423
01:11 ET6000.423
01:22 ET1000.423
01:24 ET2000.423
01:29 ET2260.423
01:36 ET6000.4233
01:38 ET1000.4224
01:45 ET1000.4224
01:51 ET7000.4224
02:02 ET68560.4224
02:07 ET7000.4237
02:09 ET1000.425
02:16 ET1000.42241
02:18 ET7000.4224
02:23 ET6000.43
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesONCR
Oncorus Inc
11.0M
-0.1x
---
United StatesBUDZ
Weed Inc
11.1M
-10.0x
---
United StatesVRAX
Virax Biolabs Group Ltd
11.2M
-6.1x
---
United StatesKTRA
Kintara Therapeutics Inc
10.8M
-0.3x
---
United StatesKZIA
Kazia Therapeutics Ltd
16.2M
-0.8x
---
United StatesBRTX
BioRestorative Therapies Inc
11.1M
-0.2x
---
As of 2023-02-08

Company Information

Oncorus, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing active viral immunotherapies to transform outcomes for cancer patients. Using its two platforms, the Company is developing a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and deliver transgenes to stimulate multiple arms of the immune system against tumors. Its lead product candidate, ONCR-177, is an intratumorally administered viral immunotherapy based on its oncolytic HSV-1 platform (oHSV Platform), which leverages the Herpes Simplex Virus type 1 (HSV-1). It is also developing a pipeline of product candidates based on its vRNA Immunotherapy Platform. This platform aims to enable repeat intravenous administration of viral immunotherapies in order to treat cancers that are less amenable to intratumoral injection due to safety and feasibility reasons, such as cancers of the lung.

Contact Information

Headquarters
4 Corporate DriveANDOVER, MA, United States 01810
Phone
857-320-6400
Fax
302-655-5049

Executives

Executive Chairman of the Board, Co-Founder
Mitchell Finer
President, Chief Executive Officer, Director
Theodore Ashburn
Chief Financial Officer
Richard Wanstall
Chief Operating Officer, Chief of Staff
Stephen Harbin
Senior Vice President - Research, Chief Scientific Officer
Christophe Queva

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$11.0M
Revenue (TTM)
$0.00
Shares Outstanding
26.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.95
Book Value
$5.03
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.